NCT02665156

Brief Summary

Objectives and Specific Aims Time efficiency of robot assisted radical cystectomy (RARC) with totally intracorporeal stapled orthotopic neobladder remains a main drawback of this procedure. According to a recent consensus panel, the benchmark for intracorporeal orthotopic neobladder should be 5 hours in high volume centers . This prospective single-stage phase 2 trial is designed to assess the time efficiency of using robotic stapler versus the conventional motorized staplers (Linear stapler articulated Endo GIA™, Covidien) in achieving the target outcome (total operative time \<5 hr). Perioperative complications (intraoperative and 30-d postoperative complications according to the Clavien classification system), 30-d/90-d/ 180-d complication and readmission rates, early functional outcomes (time to recovery of urinary continence), 180-d and 360-d neobladder stone formation rates will be analyzed to assess the safety and the cost effectiveness of the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

January 19, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 27, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

March 28, 2019

Status Verified

March 1, 2019

Enrollment Period

1.3 years

First QC Date

January 19, 2016

Last Update Submit

March 27, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improving time efficiency, achieving a total operative <5 hrs in 80% of cases (28/33)

    1 yr

Secondary Outcomes (4)

  • Perioperative complications

    6 months

  • Readmission rate

    6 months

  • Neobladder stone formation

    1-yr

  • Cost analysis

    1-yr

Study Arms (1)

Robotic Stapled orthotopic neobladder

EXPERIMENTAL

Intracorporeal stapled neobladder using robotic staplers: Partly stapled orthotopic neobladder: robotic staplers applied to create the neobladder neck and to suture the left side of the posterior aspect of neobladder. Right side of the posterior aspect of neobladder and the anterior aspect of the neobladder hand sewn.

Procedure: Intracorporeal stapled neobladder using robotic staplers

Interventions

Robot assisted radical cystecomy. Separate packages extended pelvic lymph node dissection up to aortic bifurcation. Totally intracorporeal orthotopic ileal neobladder with about 45 cm of ileum according to "Vescica Ileal Padovana".

Robotic Stapled orthotopic neobladder

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- Pathologically confirmed muscle invasive bladder cancer or recurrent high grade urothelial carcinoma (BCG failures)

You may not qualify if:

  • All absoulte contraindications to orthotopic neobladder;
  • Anesthesiologic contraindications to penumoeperitoneum and steep Trendelenburg position.
  • cT4 disease;
  • clinical evidence of metastases (cM1) outside the pelvis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

"Regina Elena" National Cancer Institute

Rome, 00144, Italy

Location

Study Officials

  • Giuseppe Simone, Ph.D.

    "Regina Elena" National Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D.

Study Record Dates

First Submitted

January 19, 2016

First Posted

January 27, 2016

Study Start

January 1, 2016

Primary Completion

May 1, 2017

Study Completion

September 1, 2018

Last Updated

March 28, 2019

Record last verified: 2019-03

Locations